Indivisible Partners
LEGN icon

Indivisible Partners’s Legend Biotech LEGN Stock Holding History

Indivisible Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$213K Buy
+10,706
New +$228K 0.01% 691

Other funds holding LEGN

Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
NLB Skladi upravljanje premozenja
NLB Skladi upravljanje premozenja Ljubljana $2.71B AUM 53.8% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
PensionDanmark
PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Pavaki Capital Management
Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Indivisible Partners's LEGN Position: Q3 2026 in Review

Indivisible Partners opened a new position in Legend Biotech (LEGN) in Q3 2026: 10,706 shares worth $213K. The stake represents 0.01% of the portfolio and ranks #691 among its holdings.

24 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Indivisible Partners held 10,706 shares of Legend Biotech worth $213K as of Q3 2026.
  • Legend Biotech was a new Indivisible Partners position in Q3 2026.
  • Legend Biotech made up 0.01% of Indivisible Partners's portfolio in Q3 2026, its #691 holding.
  • 24 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Indivisible Partners's 13F filing for Q3 2026, filed 26 Oct 2026.